Growth inhibition of rat mammary carcinoma and endocrine changes produced by 2-Br-α-ergocryptine, a suppressor of lactation and nidation-Reference-Cited by-同舟云学术

Growth inhibition of rat mammary carcinoma and endocrine changes produced by 2-Br-α-ergocryptine, a suppressor of lactation and nidation

Published:1970-10 Issue:5 Volume:6 Page:353-356
ISSN:0014-2964
Container-title:European Journal of Cancer (1965)
language:en
Short-container-title:European Journal of Cancer (1965)

Author:

Heuson J.C.,Waelbroeck-Van Gaver C.,Legros N.

Publisher

Elsevier BV

Subject

General Medicine

Reference6 articles.

1. Relation of mammary tumors to mammotropes. I. Induction of mammary tumors in rats. II. Hormone responsiveness of 3-methylcholanthrene induced mammary carcinomas. III. Hormone responsiveness of transplanted mammary tumors;Kim,1960

2. Biological problems regarding hormonal surgery;Pearson,1967

3. Prolactin-dependent rat mammary cancer: a model for man?;Pearson;Trans. Ass. Am. Physns,1969

4. Regression of prolactin-dependent rat mammary carcinoma in response to antihormone treatment;Butler,1970

5. Effect of ergocornine on ovarian synthesis of progesterone and 20 α-hydroxy-pregn-4-en-3-one in the pseudopregnant rat;Lindner;Acta Endocr,1967

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk;Nature Reviews Endocrinology;2010-10-19

2. Effect of Hormones on Carcinogenesis by Nonhormone Chemical Agents;Chemical Induction of Cancer;1995

3. Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate;Breast Cancer Research and Treatment;1992-06

4. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat;European Journal of Cancer and Clinical Oncology;1989-05

5. Bromokriptin beim chemotherapieresistenten, metastasierten Mammakarzinom;Oncology Research and Treatment;1988